Morgan Stanley Genfit S.A. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Genfit S.A. stock. As of the latest transaction made, Morgan Stanley holds 34,720 shares of GNFT stock, worth $120,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,720
Previous 25,020
38.77%
Holding current value
$120,478
Previous $149,000
13.42%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding GNFT
# of Institutions
7Shares Held
205KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny166KShares$577,3210.0% of portfolio
-
Ubs Group Ag3.05KShares$10,5760.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$2,3520.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P7266Shares$9230.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ250Shares$8670.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $173M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...